References
- Desir J, Moya G, Reish O, Van Regemorter N, Deconinck H, David KL, Meire FM, Abramowicz MJ, et al. Borate transporter SLC4A11 mutations cause both Harboyan syndrome and non-syndromic corneal endothelial dystrophy. J Med Genet. 2007;44(5):322–26. doi:10.1136/jmg.2006.046904.
- Lanzieri TM, Dollard SC, Bialek SR, Grosse SD, et al. Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. Int J Infect Dis. 2014;22:44–48.
- Dollard SC, Grosse SD, Ross DS.New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17(5):355–63. doi:10.1002/rmv.544.
- Coats DK, Demmler GJ, Paysse EA, Du LT, Libby C, et al. Ophthalmologic findings in children with congenital cytomegalovirus infection. J Am Assoc Pediatr Ophthalmol Strabismus. 2000;4(2):110–16. doi:10.1067/mpa.2000.103870.
- Anderson KS, et al. Ocular abnormalities in congenital cytomegalovirus infection. J Am Optom Assoc 1996;67(5):273–78.
- Nischal KK.A new approach to the classification of neonatal corneal opacities. Curr Opin Ophthalmol. 2012;23(5):344–54. doi:10.1097/ICU.0b013e328356893d.
- Nischal KK.Congenital corneal opacities – a surgical approach to nomenclature and classification. Eye. 2007;21(10):1326–37. doi:10.1038/sj.eye.6702840.
- Jiao X, Sultana A, Garg P, Ramamurthy B, Vemuganti GK, Gangopadhyay N, Hejtmancik JF, Kannabiran C, et al. Autosomal recessive corneal endothelial dystrophy (CHED2) is associated with mutations in SLC4A11. J Med Genet. 2007;44(1):64–68. doi:10.1136/jmg.2006.044644.
- Wilson ME.Congenital iris ectropion and a new classification for anterior segment dysgenesis. J Pediatr Ophthalmol Strabismus. 1990;27(1):48–55. doi:10.3928/0191-3913-19900101-13.
- Moazzeni H, Javadi MA, Asgari D, Khani M, Emami M, Moghadam A, Panahi-Bazaz M-R, Hosseini Tehrani M, Karimian F, Hosseini B, et al. Observation of nine previously reported and 10 non-reported SLC4A11 mutations among 20 Iranian CHED probands and identification of an MPDZ mutation as possible cause of CHED and FECD in one family. Br J Ophthalmol. 2020;104(11):1621–28. doi:10.1136/bjophthalmol-2019-314377.
- Romero MF.Molecular pathophysiology of SLC4 bicarbonate transporters. Curr Opin Nephrol Hypertens. 2005;14(5):495–501. doi:10.1097/01.mnh.0000168333.01831.2c.
- Park M, et al. Borate transport and cell growth and proliferation: not only in plants. Cell Cycle (Georgetown, Tex.). 2005;4(1):24–26. doi:10.4161/cc.4.1.1394.
- Tananuvat N, Tananuvat R, Chartapisak W, Mahanupab P, Hokierti C, Srikummool M, Kampuansai J, Intachai W, Olsen B, Ketudat Cairns JR, et al. Harboyan syndrome: novel SLC4A11 mutation, clinical manifestations, and outcome of corneal transplantation. J Hum Genet. 2021;66(2):193–203. doi:10.1038/s10038-020-00834-5.
- Javaid A, Orakzai AA.Harboyan syndrome. J Ayub Med Coll Abbottabad. 2020;32(Suppl 1)(4):S701–s703.